BioStock: Brain+ CEO - “CST is becoming the standard in dementia care”
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

BioStock: Brain+ CEO - “CST is becoming the standard in dementia care”

Brain+ is a health tech company focused on treatment and management of dementia. Centred around Cognitive Stimulation Therapy, the company’s approach has the potential to revolutionize dementia care. CEO Kim Baden-Kristensen stopped by the BioStock Studio to talk about Brain+’s path-to-market and the future of dementia management.

Watch the interview with Brain+‘s CEO Kim Baden-Kristensen at biostock.se:

Brain+ CEO: "CST is becoming the standard in dementia care" - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Nyheter om Brain+

Läses av andra just nu

Om aktien Brain+

Senaste nytt